ROPER TECHNOLOGIES INC

ROP

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 184,166Value: $82.0M

**Signal Note: Eventide ROP Initiation** Eventide's $82M ROP position likely reflects conviction in Roper's diversified industrial/software portfolio rather than a pure biotech thesis, though the company does hold select life sciences assets through subsidiaries like Inogen (respiratory devices) and Transgenomic (genomic testing). This signals confidence in Roper's defensive cash generation and potential M&A activity in high-margin software/instrumentation within medtech—areas that align with Eventide's values-based screening for companies with positive social impact.

More ROP Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: